NCT03143725View on ClinicalTrials.gov

Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral Solution

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 14, 2017

Primary Completion Date

June 6, 2017

Study Completion Date

June 6, 2017

Conditions
Healthy
Interventions
DRUG

GLPG1972

Oral administration of GLPG1972 in four different treatment conditions (Treatments A throug D)

Trial Locations (1)

Unknown

SGS Belgium Life Sciences, Antwerp

Sponsors

Lead Sponsor

Galapagos NV
All Listed Sponsors
lead

Galapagos NV

INDUSTRY